Spyre Therapeutics SYRE
NASDAQ SYRE
$104.48 -4.52 (-4.15%)
At close: Nov 10, 2026 · 4:00 PM EST

Spyre Therapeutics (SYRE) Current Assets (2015 - 2026)

Updated

Spyre Therapeutics (SYRE) posted Current Assets of $1.1 billion for Q3 2026, up 117.9% from $504.6 million a year earlier but down 6.2% from the prior quarter.

Analysis

Spyre Therapeutics (SYRE) Current Assets (2015 - 2026) Analysis & Trends

At the end of FY2025, Spyre Therapeutics' Current Assets came in at $777.78 million, up 27.8% from FY2024.

  • Annual Current Assets has increased for three consecutive years, with a five-year compound annual growth rate of 39.0% (FY2020 to FY2025).
  • In prior years, Spyre Therapeutics' Current Assets was $608.47 million in FY2024 (+78.2%), $341.53 million in FY2023 (+448.6%), $62.26 million in FY2022 (-37.0%) and $98.89 million in FY2021 (-34.0%).
  • Quarterly Current Assets has run from a low of $44.38 million in Q1 2023 to a high of $1.17 billion in Q2 2026 over five years.
  • On a year-over-year basis, Current Assets has increased in each of the last 14 quarters, with growth averaging 54.5% over the last eight quarters.
  • The strongest year-over-year quarter for Current Assets in the past five years was Q1 2024, with growth of 998.1%; the weakest was Q1 2022, with a decline of 52.1%.
  • According to Business Quant data, Current Assets for the three prior quarters was $1.17 billion (Q2 2026), $763.95 million (Q1 2026) and $777.78 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 65.26 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 56.35 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 37.48 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 38.94 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 27.35 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 27.97 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 34.36 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 16.55 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 45.01 Bn
10 Spyre Therapeutics 9.45 Bn 5.73 Bn - 1.10 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 1.10 Bn
Jun 30, 2026 1.17 Bn
Mar 31, 2026 763.95 Mn
Dec 31, 2025 777.78 Mn
Sep 30, 2025 504.60 Mn
Jun 30, 2025 538.83 Mn
Mar 31, 2025 569.77 Mn
Dec 31, 2024 608.47 Mn
Sep 30, 2024 421.08 Mn
Jun 30, 2024 435.74 Mn
Mar 31, 2024 487.27 Mn
Dec 31, 2023 341.53 Mn
Sep 30, 2023 205.95 Mn
Jun 30, 2023 239.89 Mn
Mar 31, 2023 44.38 Mn
Dec 31, 2022 62.26 Mn
Sep 30, 2022 82.22 Mn
Jun 30, 2022 96.65 Mn
Mar 31, 2022 72.60 Mn
Dec 31, 2021 98.89 Mn
API Access

Spyre Therapeutics Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=SYRE&period=max&api_key=YOUR_API_KEY